Synaptogenix Inc. (NASDAQ: SNPX) Announce Publication of Peer-Reviewed Data of Bryostatin...

0
Synaptogenix Inc. (NASDAQ: SNPX)  has announced  a peer-reviewed scientific publication in the Journal of Alzheimer’s Disease  entitled, “Bryostatin Placebo-Controlled Trials Indicate Cognitive Restoration Above...

DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology

0
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...

Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.

0
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....

Popular News

Neurotrope Inc. (NASDAQ:NTRP) Announce Commencement Of New Long Term Study Bryostatin-1...

0
Neurotrope Inc. (NASDAQ:NTRP) has announced the launch of a new second phase study of Bryostatin-1 for the treatment of Alzheimer's disease patients. Neurotrope receives $2.7...

MAKE IT MODERN

LATEST REVIEWS

MannKind Corporation (NASDAQ:MNKD) Posts Revenues Of $15.1 Million In Q2 2020

0
MannKind Corporation (NASDAQ:MNKD) reported revenues of $7 million from the sale of Afrezza and $8.1 million from the services/ collaboration segment. CEO of MannKind, Michael...

MAKE IT MODERN

PERFORMANCE TRAINING

Auris Medical Holding Ltd (NASDAQ: EARS) Clinches Trasir To Concentrate On RNA Therapeutics Development

0
Auris Medical Holding Ltd (NASDAQ: EARS) took over Trasir Therapeutics, Inc to concentrate on RNA Therapeutics development.  Inducts Samuel Wickline as CSO The company will assume...

OncoCyte Corp (NYSEAMERICAN:OCX) and the Guardian Research Network® Collaborate to Establish an Integrated Platform...

0
Cancer is a leading cause of death in the United States. Victims and their families, employers, and insurance companies spend over 150 billion dollars...

Aytu Bioscience Inc (NASDAQ:AYTU) Reports An Impressive Fiscal Q4 2020 Performance

0
Aytu Bioscience Inc (NASDAQ:AYTU) recently released its financial report for its fiscal Q4 2020 ended June 30, 2020, revealing impressive financial highlights. The company’s net...

Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) Announces Q3 2021 Financial Results And Updates On Expansion...

0
Corvus Pharmaceuticals Inc. (NASDAQ: CRVS) has announced financial results for the quarter ending September 30, 2021, and offered a business update. Corvus ended Q3 2021...

Penny Stocks In Focus HPCO, BREA, GNS

0
This weekend the news of The U.S. Department of Transportation investigating Neuralink, Elon Musk's brain-computer interface company, for allegedly unsafe packaging and...

MAKE IT MODERN

POPULAR

romabet mahbet پین باهیس bettingmagazine.org بت کارت یاس بت yekbet megapari onjabet alvinbet betboro betfa بت فوروارد 1xbet 1win betwinner 4shart.com 1xbetgiris.cam وان کیک بت وین بت ریتزوبت 1xbet-ir.com.co وان ایکس بت بت فوروارد